iCAD receives CE Mark for ProFound AI for DBT 3.0

2021 04 12 21 11 0603 Breast Cancer 3 D 400

Computer-aided detection (CAD) software developer iCAD has received the CE Mark for version 3.0 of its ProFound AI for digital breast tomosynthesis (DBT) software.

The new release delivers a 10% improvement in specificity while maintaining the software's high sensitivity, according to the vendor. In addition, ProFound AI for DBT 3.0 features 40% faster processing times on the company's new PowerLook platform, iCAD said.

After analyzing each DBT image, the software detects malignant soft-tissue densities and calcifications, assigning "certainty of finding" for each detection, and it also provides an overall score for each case that represents the algorithm's confidence of malignancy.

Page 1 of 110
Next Page